Basic Information
Genovis was founded in 1999 and later developed several unique SmartEnzymes, facilitating the development and quality control of biopharmaceuticals. These products enable customers to perform faster analyses with higher quality compared to competing technologies. In addition to physical products, all customers receive technical support, and Genovis also offers the development of customized methods. The company is equipped with fully-equipped facilities for efficient product development during the early research phase, as well as subsequent production processes and final product format development. An important cornerstone and competitive advantage of Genovis' R&D activities is the collaboration with academic groups focused on characterizing novel enzymes. Equally valuable are customer relationships, which allow product development to meet customer needs.
Genovis
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 1999
order@genovis.com

